Related Experiment Video
Updated: Feb 9, 2026

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death
Yutaro Yamamoto1,2, Nobuyoshi Sasaki2,3, Kosuke Kumagai1
1Department of Neurosurgery, National Defense Medical College.
Abstract:
Glioblastoma (GBM) still carries a poor prognosis due to the refractoriness against antitumor drugs. Temozolomide (TMZ), one of the few standard therapy drugs against GBM worldwide, has only limited effect due to acquired TMZ resistance of GBM. Therefore, development of novel therapeutic methods to overcome the TMZ resistance of GBM is urgent. The brain is the most cholesterol-rich organ in the human body, so modulation of cholesterol in tumor cells originating from the brain including GBM may be a tumor-specific therapeutic strategy including enhancement of TMZ effects. The unique lipid metabolism of glioma has recently been reported, but the involvement of intracellular cholesterol in TMZ therapy is yet to be fully elucidated. This review summarizes the effect of modulation of intracellular cholesterol level on cancer therapy including GBM treatment and the implications for TMZ therapy. Our recent findings about the involvement of intracellular cholesterol in TMZ-induced GBM cell death are described.
Insights
Glioblastoma treatment resistance can be overcome by targeting intracellular cholesterol. Modulating cholesterol levels enhances temozolomide therapy effectiveness, offering a novel strategy for glioblastoma patients.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Drug Resistance Mechanisms
Background:
- Glioblastoma (GBM) presents a poor prognosis due to resistance to standard therapies like temozolomide (TMZ).
- Acquired resistance to TMZ significantly limits its therapeutic efficacy in GBM patients.
- Novel therapeutic strategies are urgently needed to overcome TMZ resistance in glioblastoma.
Purpose of the Study:
- To review the impact of modulating intracellular cholesterol levels on cancer therapy, particularly for GBM.
- To explore the potential of targeting cholesterol metabolism as a tumor-specific therapeutic strategy for glioblastoma.
- To elucidate the role of intracellular cholesterol in temozolomide-induced cell death in GBM.
Main Methods:
- Literature review on cholesterol metabolism in cancer and its therapeutic implications.
- Analysis of recent findings on intracellular cholesterol's involvement in TMZ-induced GBM cell death.
Main Results:
- Modulation of intracellular cholesterol levels shows promise as a therapeutic strategy in cancer, including GBM.
- Targeting cholesterol metabolism may enhance the effectiveness of temozolomide therapy.
- Intracellular cholesterol plays a significant role in the mechanisms of temozolomide-induced glioblastoma cell death.
Conclusions:
- Targeting intracellular cholesterol represents a potential approach to overcome temozolomide resistance in glioblastoma.
- Understanding glioma's unique lipid metabolism, specifically cholesterol, is crucial for developing effective GBM therapies.
- Further research into cholesterol modulation could lead to improved treatment outcomes for glioblastoma patients.
More Related Videos
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Intracellular Signaling Cascades
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Induced Pluripotent Stem Cells

